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Polymeric nanoparticles (PLGA) have been developed for the encapsulation and controlled release of quercetin and catechin.
Nanoparticles were fabricated using a solvent displacement method. Physicochemical properties were measured by light scattering,
scanning electron microscopy and ζ-potential, X-ray diﬀraction, infrared spectroscopy and diﬀerential scanning calorimetry.
Encapsulation eﬃciency and in vitro release profiles were obtained from diﬀerential pulse voltammetry experiments. Antioxidant
properties of free and encapsulated flavonoids were determined by TBARS, fluorescence spectroscopy and standard chelating
activity methods. Relatively small (d ≈ 400 nm) polymeric nanoparticles were obtained containing quercetin or catechin in a
non-crystalline form (EE ≈ 79%) and the main interactions between the polymer and each flavonoid were found to consist of
hydrogen bonds. In vitro release profiles were pH-dependant, the more acidic pH, the faster release of each flavonoid from the
polymeric nanoparticles. The inhibition of the action of free radicals and chelating properties, were also enhanced when quercetin
and catechin were encapsulated within PLGA nanoparticles. The information obtained from this study will facilitate the design
and fabrication of polymeric nanoparticles as possible oral delivery systems for encapsulation, protection and controlled release of
flavonoids aimed to prevent oxidative stress in human body or food products.
1. Introduction
Lipid oxidation is one of the most important processes that
can cause deterioration in lipid bearing foods, which leads to
the development of rancidity, oﬀ-flavor compounds, poly-
merization, and the decrease of the shelf life and nutritive
value of food products [1, 2]. In addition, some studies
have demonstrated that lipid oxidation is related to some
stress oxidative diseases, such as diabetes mellitus, cancer,
and cardiovascular diseases [3–6]. Oxidative degradation of
lipids can be initiated by radical oxygen species (superox-
ide radicals, hydroxyl radicals, peroxyl radicals, etc.) and
nonradical related compounds (hydrogen peroxide, singlet
oxygen, ozone, etc.). Lipid oxidation can be accelerated by
the presence of transition metal ions (Fe2+, Cu1+, Co1+)
which are present as ubiquitous impurities in food systems
or human plasma [7, 8]. In this context, some methods
have been used in order to delay the oxidation process
in food products or in the human body. In this way,
polyphenolic compounds, such as quercetin and catechin,
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have gained great interest within the pharmaceutical and
food industries due to their beneficial properties, such as
antioxidant, antiradical, anti-inflammatory, antimutagenic,
anticarcinogenic, antiangiogenic, antibacterial, antiviral, and
antiaging eﬀects, stimulating antioxidant enzymes in the
human body [9–12]. Antiradical properties of quercetin
and catechin have demonstrated that they can inhibit lipid
oxidation in diﬀerent systems; thus, catechin and quercetin
have been proposed for the formulation of novel pharma-
ceutical or functional food products. However, the use of
these two flavonoids has been limited due to their poor
water solubility and instability under conditions encountered
during food/pharmaceutical products processing (temper-
ature, light, pH), in the gut (pH, enzymes, presence of
other nutrients) or during storage (light, oxygen) [13, 14].
These factors limit the beneficial properties and potential
health benefits of these compounds in functional food or
pharmaceutical products [15]. Controlled delivery systems,
such as nanoparticles, have shown their potential to protect,
control the release, and increase the action of diﬀerent
bioactive compounds [16, 17].
Therefore, the aim of this study was to encapsu-
late quercetin or catechin within polymeric nanoparticles,
using the biocompatible copolymer poly (D, L lactide-co-
glycolide) (PLGA) and characterize their physicochemical
and antioxidant properties. One of the most important
aspects of this study is the determination of the encap-
sulation eﬃciency and in vitro release profiles at diﬀerent
pH values using diﬀerential pulse voltammetry (DPV). At
the same time, evaluating the eﬀect of free or encapsulated
quercetin or catechin over free radicals that are produced
during processes in the human body will facilitate the
understanding of how these systems could act in novel
commercial products or even in the human organism.
The knowledge obtained from this investigation could
also facilitate the design of eﬀective delivery systems for the
encapsulation, protection, and release of bioactive flavonoids
that have potential to improve human health or increase
the shelf life of pharmaceutical or food products. These
nanoparticulated systems may be suitable for their use in
pharmaceutical applications and for the development of
medical foods in the near future.
2. Materials andMethods
2.1. Materials. Quercetin, (+) catechin, polyvinyl alcohol
(PVA), β-nicotinamide adenine dinucleotide (NADH),
phenazine methosulfate (PMS), dimethylsulphoxide
(DMSO), potassium bromide (KBr), and nitroblue
tetrazolium (NBT) were purchased from Sigma Chemical
Co. (St. Louis, MO, USA). 50 : 50 Poly (D, L-lactide-
co-glycolide) (PLGA) was obtained from Lakeshore
Biomaterials (Birmingham, AL, USA). Acetone and ethanol
(analytical grade), phosphoric acid (H3PO4), boric acid
(H3BO3), and acetic acid (CH3–COOH) were obtained from
J. T. Baker (Mallinckrodt Baker, Inc., Phillipsburg, NJ, USA).
High quality water purified in a Milli-Q system (Millipore,
Bedford, MD, USA) was used in all experiments.
2.2. Methods
2.2.1. Preparation of Polymeric Nanoparticles. PLGA
nanoparticles were prepared by the solvent displacement
method with minor modifications using a previously
described protocol [18, 19]. PLGA (200mg) was dissolved in
20mL of acetone under magnetic stirring for 30min at 25◦C.
The resulting PLGA solution was then slowly added to a 5%
PVA aqueous solution (40mL) using a syringe. The solution
was then homogenized using a high shear mixer (Ultraturrax
IKA T25, IKA/Works, Inc., NC, USA) at 19,000 RPM for
5min. The organic solvent and water were evaporated
for 30min under vacuum using a rotary evaporator. The
nanoparticles formed were washed with distilled water and
ultracentrifuged (Optima XL-80K, Beckman Coulter, Inc.,
CA, USA) at 20,000 RPM for 20min at 5◦C. The pellet
was resuspended in distilled water for 24 h and then stored
for 12 h at −20◦C in a freezer (General Electric, USA).
The frozen nanoparticle dispersion was freeze dried at
−70◦C (10−3 Torr) for 48 h using a commercial freeze drier
(LabconcoFreezone 6, Labconco Corp., MO, USA). The
lyophilized nanoparticle dispersions were stored in desic-
cators containing dehydrating salts at 25◦C until used. To
prepare quercetin or catechin-loaded PLGA nanoparticles,
separately, quercetin and catechin (10mg) were dissolved
into the PLGA-acetone solution prior to nanoparticle
synthesis. Three independent batches of PLGA nanoparticles
were prepared with or without quercetin or catechin for
physicochemical and antioxidant characterizations.
2.2.2. Characterization
Particle Size and Charge Measurements. The mean particle
diameter and polydispersity index (PI) of the nanoparticles
were determined by dynamic light scattering (Nanosizer
N4 Plus, Beckman Coulter Inc., CA, USA). The samples
were diluted with distilled water to ensure that the number
of particles counted per second was within the range of
the instrument’s sensitivity. Measurements were made at an
angle of 90◦ for 180 s at 25◦C. The electrical charge on
the nanoparticles was measured by particle electrophoresis
(Zetasizer Zen Systems 3600, Malvern Instruments Ltd.,
UK) after they had been diluted in deionized water to
avoid multiple scattering eﬀects and then placed in a folded
capillary cell (25◦C). Measurements were made in triplicate,
and the results are shown as mean ± standard error.
Morphology. The morphology of the nanoparticles was
studied by Environmental Scanning Electron Microscopy
(ESEM). Nanoparticle samples were coated with a ≈20 nm
gold film and then observed under high vacuum conditions
within an electron microscope (Phillips XL30, FEI Company,
OR, USA).
Determination of Drug Entrapment Eﬃciency (EE). Drug
entrapment eﬃciency (EE) was determined by Diﬀerential
Pulse Voltammetry (DPV) following a protocol previously
described with minor modifications [20]. The electro-
chemical experiments were performed using a BAS-Epsilon
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Potentiostat/Galvanostat instrument coupled to a C3-BAS
Cell Stand. DPV experiments were performed in previously
deoxygenated solutions by bubbling pure nitrogen gas for
20min and using an electrochemical 10mL cell in which
a platinum (Pt) counter, a silver/silver chloride (Ag/AgCl),
3M NaCl reference, and a glassy carbon working electrode
(0.08 cm2) were properly fitted. Before each experiment, the
working electrode was polished using a slurry of 0.05 μm
alumina particles dispersed in purified water on a felt surface.
Parameters for DPV were 70mV pulse amplitude and a
scan rate of 5mV/s. An aliquot of nanoparticles (≈10mg)
was dispersed in DMSO for 48 h by magnetic stirring in a
glass vial covered with aluminum foil; pure nitrogen was
bubbled before sealing the vial. 30 μL of nanoparticle/DMSO
dispersions were then added to the electrochemical cell
containing 3mL of deoxygenated Britton-Robinson buﬀer
pH 7. The flavonoid concentration was calculated used stan-
dard calibration curves. The flavonoid content remaining
within the nanoparticles was calculated from the diﬀerence
between the total amount of drug added and the amount
of drug released in the aqueous medium. The encapsulation
eﬃciency of the flavonoids was determined using as follows:
EE (%) = Amount of QC in entrapment− amount of QC in supernatant
Total amount of QC in formulation
× 100. (1)
2.2.3. Diﬀerential Scanning Calorimetry (DSC). The
phase behavior of quercetin, catechin, physical mixtures
quercetin/PLGA, catechin/PLGA, quercetin-free, catechin-
free, catechin-loaded, and quercetin-loaded nanoparticles
(2.0mg ± 0.2) was determined by DSC. The scan rate
employed was 10◦C/min in the temperature range from 0 to
340◦C under nitrogen atmosphere at flow rate of 50mL/min
(DSC Q10, TA Instruments, DE, USA) [15]. Samples were
analyzed in triplicate.
2.2.4. X-Ray Diﬀraction (XRD). XRD patterns of quercetin,
catechin, physical mixtures of quercetin/PLGA and cat-
echin/PLGA, quercetin-free, catechin-free, and quercetin-
loaded and catechin-loaded PLGA nanoparticles (≈15mg)
were recorded using an X-ray diﬀraction instrument (Dmax
2100 Rigaku diﬀractometer, Rigaku Americas, TX, USA)
employing a cobalt (Co) tube at λ = 1.78899A, running at
30 kV and 16mA.
2.2.5. Diﬀuse Reflectance of Infrared by Fourier Transform
(DRIFT). Infrared absorption spectra of quercetin, cat-
echin, quercetin-free, catechin-free, and quercetin-loaded
and catechin-loaded PLGA nanoparticles were examined
by DRIFT spectroscopy (Spectrum GX spectrophotometer,
Perkin-Elmer, MA, USA) with a diﬀuse reflectance accessory
(Pike Technology model). All samples were previously stored
in a desiccator containing silica gel at least 48 h at room
temperature to ensure minimal moisture content. 2.4mg of
each sample were mixed with 97.6mg of KBr, previously
dried in an oven for 24 h at 135◦C to remove moisture.
The spectra were collected at 4 cm−1 resolution, with the
wavenumber range of 400–4000 cm−1. 16 scans were taken
with the average from each spectrum recorded as ACII files.
The pure KBr background spectrumwas subtracted from the
sample spectrum.
2.2.6. Drug In Vitro Release from Nanoparticles. Drug
in vitro release tests were performed using the described
electrochemical protocol in [20]. Quercetin-loaded and
catechin-loaded PLGA nanoparticles (5mg) were added into
a Britton-Robinson buﬀer (pH adjusted to 7.4, 4.5, or 2
using HCl) and were magnetically stirred for 32 h. The
amount of quercetin released from the nanoparticles was
monitored at 0.25, 0.5, 1, 2, 4, 8, 12, 24, 26, 28, 30, and 32 h
by the DPV technique. In order to maintain the chemical
stability of quercetin released from nanoparticles during
experiments, Britton-Robinson buﬀer was deoxygenated
before each experiment, by bubbling high purity N2 gas
for 10min in order to eliminate the presence of molecular
oxygen that can oxidize the quercetin molecules.
2.2.7. Antioxidant Capacity of Free/Encapsulated
Quercetin and Catechin
Superoxide Anion-Scavenging Activity Assay (O2
•−). The
antioxidant capacity of free and encapsulated quercetin or
catechin was estimated using the superoxide anion (O2
•−)
scavenging activity assay, adapting our system to the previous
established protocols [16]. O2
•− radicals were formed in
phosphate buﬀer (PBS) 0.1M at pH 8. In a quartz cuvette
PBS (1.2mL), β-nicotinamide adenine dinucleotide (NADH,
reduced form, 0.7mM)/nitroblue tetrazolium (NBT, 17mM)
(800 μL), and 200 μL of Qc/Cate-loaded NPs solutions at
three diﬀerent flavonoid concentrations (7, 21 and 35 μM,
adjusted to the NBT final concentration) were added. The
mixture was kept in incubation for 120min in a Varian Cary
50-Bio UV-Vis spectrophotometer (Agilent Technologies
Brasil, SP, Brazil) under magnetic stirring (500 RPM) at
37◦C. After incubation, 200 μL of phenazine methosulfate
(PMS) (diluted in PBS pH 8, 4 μM) were added. The
inhibition of NBT oxidation was continuously monitored for
two minutes at 560 nm. PBS and PLGA/PBS solutions were
used as negative controls and flavonoid standards were used
as positive controls. The inhibition of NBT oxidation was
calculated using as follows:
I(%) = 100− K1
K0
× 100, (2)
where I is the percentage of oxidation inhibition, K1 is
the slope variation of the sample, and K0 corresponds to
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the slope variation of the blank. Samples were analyzed in
triplicate (each batch) and the results are shown as mean ±
SE.
Lipid Peroxidation Assay by Fluorescence. We evaluated the
ability of free or encapsulated quercetin and catechin to
inhibit the peroxidation of liposomes by peroxyl radicals,
following established protocols [21]. Briefly, multilamellar
vesicles of soybean phosphatidylcholine [22] at an initial
concentration of 2.8mM in phosphate buﬀer (PBS, 50mM,
pH 7.4) were prepared by vortexing and then by sonica-
tion for 14min at 35◦C. Unilamellar PC liposomes were
obtained by extruding at least 15 times the multilamellar
PC liposomes suspension through a Mini-Extruder (Avanti
Polar Lipids, Inc., USA) within a 0.1 μm polycarbonate
membrane. The resulting solution was kept at 5◦C and pro-
tected from light until use. An oxidation-sensitive fluores-
cent dye 4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-
3a,4a-diaza-s-indacene-3-undecanoic (C11-BODIPY581/591)
(40 μm) was incorporated into the bilayer structure of the
phospholipid liposomes. Then, in a quartz cuvette 700 μL of
PC/C11-BODIPY581/591 solution, 250 μL of free/encapsulated
quercetin solution at three diﬀerent concentrations (0.02,
0.06, and 0.1 μM in PBS 50mM, pH 7.4), and 50 μL of 2,2′-
azobis (2′-methylpropionamidine) dihydrochloride (AAPH,
100mM) to initiate the reduction of C11-BODIPY581/591
were placed. Samples were magnetically stirred at 37◦C for
2min and then analyzed using a fluorescence spectropho-
tometer (F-4500, Hitachi, Ltd., USA). The fluorescence
kinetics was continuously monitored for 60min (λexcitation =
580nm, 600nm = λemission, Excitation slit = 10 nm, Emulsion
slit = 5 nm). PBS 50mM, pH 7.4 was used as negative control.
Metal Chelating Activity Assay. The chelating activity of Fe2+
was measured adapting our system to previously established
protocols [23, 24]. Briefly, free or encapsulated quercetin
and free or encapsulated catechin were kept separately under
magnetic stirring at 42 rpm for 30 hrs at 25◦C using a
Daiki water bath equipped with magnetic stirring (Daiki
Science Co., Ltd., Republic of Korea). Aliquots of each
sample (500 μL) at 0, 4, 12, 18, 24 y 30 h were taken and
ultracentrifuged at 12000 rpm for 5min at 5◦C using a
Hermle refrigerated Z323K high performance centrifuge
apparatus (HERMLE Labortechnik, Germany). Then 30 μL
of the supernatant and 150 μL of FeCl2 were added to a 96-
well microplate. This mixture was allowed to stand for 5min
at darkness, and then 60 μL of ferrozine (5mM) was added
to the mixture, which was vigorously stirred and allowed to
stand for 10min in darkness. The absorbance of the solution
was measured at 562 nm using a Spectra Max 190 microplate
reader (Molecular Devices, Inc., USA). The percentage of
iron chelating activity was calculated using as follows:
IC (%) = 100×
(
1− Asample
Acontrol
)
, (3)
where Acontrol is the absorbance of Fe2+ + ferrozine and
Asample corresponds to the absorbance of a given sample.
Results were obtained from two individual experiments
performance by triplicate. The results are expressed as
mean ± SE.
3. Results
3.1. Physicochemical Properties of Nanoparticles
3.1.1. Morphological and Electrical Properties of Polymeric
Nanoparticles. The functional performance of nanoparticle-
based delivery systems depends on the physicochemical
properties of the nanoparticles, such as size, morphology,
charge, and physical state [25, 26]. We therefore measured
the mean particle diameter and ζ-potential of the polymeric
nanoparticles produced in this study (Table 1). Relatively
small particles (mean diameters from 385 to 410 nm)
with narrow distributions (PI from 0.173 to 0.39) were
obtained. The electron microscopy images confirmed that
the free and loaded PLGA nanoparticles were relatively
small spheres with similar dimensions (Figure 2). These
results disagree with other studies that have reported
smaller (≈200 nm) quercetin-loaded PLGA nanoparticles
[27]. Molecular weight (MW), concentration of polymer
used, and concentration of encapsulated active, are factors
that can aﬀect the final size of the particles [27, 28]. The MW
of the PLGA used in this study was higher (60 kDa) than
that used in other works; apparently the higher MW of the
PLGA used in this study increased the viscosity of the internal
phase, leading to a decreased net shear stress, thus producing
larger nanoparticles. The PI values, on the other hand,
indicated that the free and loaded nanoparticles obtained by
the displacement solvent method were homogeneous, and
that the method employed was reproducible and stable [29].
The electrical charge (ζ) of the free and loaded flavonoid
polymeric nanoparticles was negative at pH 7, an observation
that can be attributed to the presence of ionized carboxyl
groups on the PLGA matrix [30]. Diﬀerences in ζ values
were also observed between flavonoid free-nanoparticles and
quercetin-loaded PLGA nanoparticles or catechin-loaded
PLGA nanoparticles (−31.4mV, −44.6mV, and −29.8mV,
resp.). These results indicate that the presence of each
specific flavonoid alter the electrical charge of the polymeric
nanoparticles. However, the presence of each flavonoid
within PLGA nanoparticles may not aﬀect the stability of
the nanoparticles given by ζ in aqueous dispersions. Some
authors have indicated that with ζ values ≈+30mV or
≈ −30mV there are enough repulsion forces to avoid
particle aggregation [31, 32]. Therefore, the ζ values for the
polymeric nanoparticles obtained in this study indicate that
there are strong electrostatic repulsion forces that prevent
particle aggregation.
3.2. Encapsulation Properties of Polymeric Nanoparticles. The
encapsulation eﬃciency (EE) of quercetin and catechin
within the PLGA nanoparticles were around 79% and 76%,
respectively, (Table 1). These results are lower than those of
reported studies, where ≥95% of EE for quercetin in PLA
nanoparticles were obtained [33]. Our results suggest that
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Table 1: Mean particle size, polydispersity index, Zeta potential, and encapsulation eﬃciency of the PLGA NPs and quercetin/catechin-
loaded PLGA NPs.
NPs Particle size (nm) Polydispersity index Z potential (ζ) (mV) E.E. (%)
Placebo 387.27± 14.5a 0.173± 0.092a −31.47± 1.01a —
PLGA Quercetin 399.67± 10.86a 0.262± 0.16b −44.67± 0.48b 79.84± 2.5a
Catechin 410.59± 9.66a 0.39± 0.125c −29.83± 0.21a 76.14± 6.13a
Results are expressed as the mean ± S. E. of three replicates with three repetitions. Diﬀerent letters indicate significant diﬀerence (P < 0.05) between rows
compared with placebo PLGA.
O
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HO
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Figure 1: Molecular structure of quercetin (a) and catechin (b).
some quercetin may have been present within the surround-
ing aqueous phase, promoted apparently by the concentra-
tion of PVA used, which increased the water solubility of both
flavonoids and thus more flavonoid molecules may partition
out rapidly to the aqueous phase during the emulsification
process therefore decreasing EE [27, 34].
3.3. Characterization of Nanoparticle Matrix Properties.
Information on the structural organization of the bioactive
molecules and polymeric matrix within the nanoparticles
was determined by diﬀerential scanning calorimetry (DSC),
infrared spectroscopy, and X-ray diﬀraction.
DSC is a powerful tool for the analysis of polymer-drug
interactions and has previously been used to show that the
drug and polymer are molecularly dispersed [35]. The phase
transition analyses of quercetin, catechin, physical mixtures
of quercetin/PLGA and catechin/PLGA, free-flavonoid PLGA
nanoparticles, and flavonoid-loaded PLGA nanoparticles are
shown in Figure 3. TheDSC curves of quercetin (Figure 3(a))
showed two endothermic transitions at 134 and 325◦C
corresponding to dehydration (solid quercetin is initially
hydrated) and melting of quercetin, respectively, [15, 36].
The DSC curves for catechin (Figure 3(b)) showed diﬀerent
endothermic transitions at 122 and 144◦C, which correspond
to the dehydration of hydrated catechin standard, 175 and
215◦C related to the melting point of catechin conform-
ers and at 294◦C corresponding to the decomposition of
the catechin molecule [37, 38]. For flavonoid-free PLGA
nanoparticles, the DSC curves showed one endothermic
peak around 52◦C, corresponding to the glass transition
temperature (Tg) of the polymer [39, 40]. Physical mixtures
of quercetin/PLGA and of catechin/PLGA (Figures 3(a) and
3(b), resp.) gave DSC profiles that exhibited a series of
thermal transitions that correspond to those observed for
PLGA, quercetin, and for catechin alone. However, there
were some changes in the location of these transition peaks
and some newly formed signals; these changes in peak
positions suggest that there were interactions between PLGA
and quercetin or catechin that resulted in the formation of a
new structural organization of polymer and flavonoid, For
quercetin-loaded or catechin-loaded PLGA nanoparticles,
the DSC curves showed no thermal transitions correspond-
ing to pure quercetin or pure catechin but showed a shifted
endothermic peak that correspond to the Tg of the PLGA
polymer. These results indicate that quercetin or catechin
is dispersed in a noncrystalline state within the polymeric
matrix of PLGA nanoparticles. Also, the shift in the Tg of
the PLGA polymer suggests weak interactions between the
PLGA matrix and quercetin or catechin, as described above.
Our results are supported by the findings of other authors
[29, 40–42].
The XRD patterns for both flavonoids, physical mixtures
of each flavonoid with PLGA, free PLGA nanoparticles, and
flavonoid-loaded PLGA nanoparticles are shown in Figure 4.
For PLGA, the XRD pattern showed no peak, a fact that
indicated that the polymer is amorphous [40, 42]. Pure
quercetin and pure catechin exhibited characteristic signals
of their crystalline structures [43–45]. The physical mixtures
of quercetin and PLGA and catechin and PLGA also exhibited
a number of diﬀerent peaks; however, these peaks were
6 Journal of Nanomaterials
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(c)
Figure 2: SEM micrographies of PLGA nanoparticles (a), quercetin-loaded PLGA nanoparticles (b), and catechin-loaded PLGA
nanoparticles (c).
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Figure 3: DSC thermograms for free PLGA nanoparticles (a) and (b), quercetin (a), quercetin/PLGA physical mixtures (a), and quercetin-
loaded PLGA nanoparticles (a), catechin (b), catechin/PLGA physical mixtures (b), and catechin-loaded PLGA nanoparticles (b).
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Figure 4: XRD spectra of catechin-loaded PLGA nanoparticles (a),
quercetin-loaded PLGA nanoparticles (b), catechin/PLGA physical
mixtures (c), quercetin/PLGA physical mixtures (d), catechin (e),
quercetin (f), and free PLGA nanoparticles (g).
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Figure 5: DRIFT spectra of free PLGA nanoparticles (a), quercetin
(b), and quercetin-loaded PLGA nanoparticles (c). DRIFT spec-
trum is the mean of 16 scans.
slightly shifted from their original positions, and also while
new peaks were observed, others disappeared. These results
confirmed the findings obtained from DSC experiments
and suggest that weak interactions occur between quercetin
or catechin with the PLGA polymer matrix. The absence
of peaks corresponding to the pure flavonoids on the
XRD patterns for quercetin-loaded PLGA nanoparticles
or catechin-loaded PLGA nanoparticles indicate that each
flavonoid mainly exists dispersed in a noncrystalline state
within the PLGA polymeric matrix.
Information on the nature of the molecular interactions
within the solid matrix of the nanoparticles was obtained
using Diﬀuse Reflectance of Infrared by Fourier Transform
(DRIFT) [46]. DRIFT spectra for pure quercetin, pure
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Figure 6: DRIFT spectra of free PLGA nanoparticles (a), catechin
(b), and catechin-loaded PLGA nanoparticles (c). DRIFT spectrum
is the mean of 16 scans.
catechin, active-free PLGA nanoparticles, quercetin-loaded
PLGA nanoparticles, and catechin-loaded PLGA nanopar-
ticles are shown in Figures 5 and 6. The DRIFT spec-
tra for free PLGA nanoparticles showed the characteristic
bands of the polymer, –CH, –CH2, –CH3 stretching (2850–
3000 cm−1), carbonyl –C=O stretching (1700–1800 cm−1),
C–O stretching (1050–1250 cm−1), and –OH stretching
(3200–3600 cm−1) [34, 40]. For quercetin, the DRIFT spectra
showed the characteristic bands corresponding toOH groups
(3700–300 cm−1), to C=O absorption (1662 cm−1), bands
of C–C stretching (1618 cm−1), C–H bending (1456, 1383,
and 866 cm−1), a band attributed to the C–O stretching
of the oxygen in the ring (1272 cm−1), and the region
for C–O stretching (1070–1150 cm−1). These findings are
consistent with previous studies [44, 46]. For pure catechin,
DRIFT spectra exhibited the characteristic bands corre-
sponding to OH stretching (3600–3200 cm−1), C=C stretch-
ing (1600–1400 cm−1), O–H stretching (1800–1670 cm−1),
C–O stretching of the oxygen in the ring (1272 cm−1), and
the characteristic peaks for the disubstituted aromatic ring
(1200–900 cm−1). The presence of these bands is also in
agreement with previous studies [37, 47]. For quercetin-
loaded and catechin-loaded PLGA nanoparticles, DRIFT
showed that the OH stretching band (3200–3600 cm−1) is
slightly shifted and increased in terms of energy absorption.
These observations suggest that quercetin and catechin are
associated with the PLGA polymer by hydrogen bonds.
Also, in the quercetin-loaded PLGA nanoparticles, the band
corresponding for C=O stretching (1700–1800 cm−1) was
broader, indicating that quercetin is associated with the
PLGA polymer by interactions between the carbonyl and
the carboxyl groups of the flavonoid and the polymer. In
addition, DRIFTmeasurements confirmed the encapsulation
of quercetin and catechin within the PLGA nanoparticles.
3.4. Quercetin and Catechin Release from Nanoparticles. In
this section, we investigated the release of quercetin and
catechin from PLGA nanoparticles as a function of pH.
The experiments were performed using a Briton-Robinson
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Figure 7: Current signals of quercetin and catechin obtained by
the release from loaded PLGA nanoparticles at Britton-Robinson
buﬀer (pH 2, 4.5, and 7.2) during 32 h of analysis period. Results
are expressed as mean ± SD of three individual experiments.
buﬀer at diﬀerent pH values, simulating the pH conditions
of the stomach (2–4.5) and from the small intestine (6-7),
in the absence of enzymes. These results may be helpful
for understanding the protection and release of bioactive
flavonoids within acidic pH conditions, such as stomach
or some food products, and at neutral pH conditions in
the small intestine. In this way, we determined the in
vitro release profiles for each flavonoid from polymeric
nanoparticles using a diﬀerent method from those that have
been commonly used (e.g., HPLC, UV-VIS, and fluoresce
spectroscopy). The advantage of using DPV is that this
technique allows to monitor in real time the release of the
bioactive compounds from the nanoparticles, using at the
same time low amounts of solvents and thus lowering the
experimentation costs.
Figure 7 shows the current responses (I/μA) obtained for
quercetin and for catechin release fromPLGANPs in Britton-
Robinson buﬀer (pH 7.2, 4.5, and 2) during a 32 h time
period. These values were interpolated in calibration curves
(concentration versus current responses) that were used to
determine the concentration and percentage of flavonoid
released during the experimentation time. The in vitro
release of quercetin and catechin from PLGA nanoparticles
(Figure 8) showed a biphasic release in the first 4 h, followed
by a more gradual release at longer times until 65% and
85% of released quercetin and catechin, respectively, were
achieved. As some authors have claimed, the burst release of
each flavonoid species can be attributed to the diﬀusion of
flavonoid molecules that are dispersed closer to the surface
of the PLGA nanoparticles [28, 41, 48]. In addition, these
profiles showed that as the pH becomesmore acid, the release
of both flavonoids is increased. This finding is related to
the PLGA degradation, which is promoted in acidic media
[49]. The diﬀerences observed in the release of quercetin
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Figure 8: Percentage of quercetin and catechin released from PLGA
nanoparticles in Britton-Robinson buﬀer (pH 2, 4.5, and 7.2).
Results are expressed as mean± SD of three individual experiments.
and catechin are related to specific interactions of the PLGA
polymer and each flavonoid. The release of quercetin, for
instance, is slower than that of catechin. This observation
is probably due to an additional interaction of quercetin
with PLGA, the interaction between carbonyl and carboxyl
groups of the polymer and flavonoid molecules. As expected,
some studies have demonstrated that when the polymer and
the encapsulated active compounds have carboxyl-carbonyl
interactions, the release rate of the active species decreases
remarkably [30]. Therefore, catechin, which does not have
a carboxyl group in its chemical structure (Figure 1), is
released faster from PLGA nanoparticles than quercetin.
3.5. Antioxidant Capacity
3.5.1. Superoxide Anion-Scavenging Activity Assay (O2
•). We
also evaluated the capacity of free or encapsulated quercetin
and of free or encapsulated catechin to inhibit the action of
the O2
• radical. In the NBT/NADH system, PMS reacts with
NADH removing an electron, which is transferred to molec-
ular O2, generating the radical O2
•. This radical species read-
ily reduces NBT, causing the formation of a purple color and
the consequent formation of formazan precipitates. Figure 9
shows the percentages of NBT reduction of free PLGA
nanoparticles, free or encapsulated quercetin, and free or
encapsulated catechin. Our results showed that encapsulated
quercetin or catechin produced greater inhibition of NBT
reduction than free flavonoids. These findings suggest that
the flavonoid molecules dispersed in the PLGA nanoparticles
are protected from molecular oxygen that could be produced
during the 2 h stirring incubation process. Therefore, after
incubation, encapsulated quercetin or catechin were released
and scavenged the O2
• radicals, as opposed to the case
of free flavonoids, which are degraded after incubation,
therefore decreasing their scavenger activity. Even when we
showed that catechin is more rapidly released from PLGA
Journal of Nanomaterials 9
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Figure 9: Inhibition of NBT reduction of free quercetin, free
catechin, quercetin-loaded PLGA nanoparticles, and catechin-
loaded PLGA nanoparticles at three diﬀerent concentrations (7,
21, and 35 μM). All results are expressed as mean ± SE of three
repetitions with at least two replicates. ∗∗ and ∗∗∗ significantly
diﬀerent (P < 0.5) from free flavonoids (positive control) and free
PLGA NPs (negative control).
nanoparticles, quercetin showed a higher radical scavenging
activity, mainly due to the presence of the C=O group and
a double bond between C-2 and C-3 in the ring C in
the quercetin structure, which allows this species to have
a greater antiradical activity than catechin [50–52]. These
results suggest that quercetin-loaded PLGA nanoparticles
may be suitable to protect food from rancidity lead by free
radical such as superoxide anion radicals.
3.5.2. Lipid Peroxidation Assay by Fluorescence. As previously
mentioned, lipid oxidation is one of the most problem-
atic deterioration processes occurring in foods containing
unsaturated lipids, which leads to the development of ran-
cidity, oﬀ-flavors, and polymerization reactions that reduce
the shelf life and nutritive value of food products. Lipid
oxidation may also generate undesirable biologically active
species that are involved in cardiovascular and inflammatory
disease processes [53–55]. For these reasons, we evaluated
the ability of free and encapsulated flavonoids to inhibit
lipid peroxidation of phospholipid liposomes. In this way,
the ability of free and encapsulated quercetin and free and
encapsulated catechin to inhibit lipid peroxidation was also
monitored using fluorescent spectroscopy (Figure 10). An
oxidation-sensitive fluorescent dye (C11-BODIPY581/591) was
incorporated into the bilayer structure of the phospholipid
liposomes. This dye loses fluorescence when it is reduced
by peroxyl (ROO•) radicals, and so a reduction in the
fluorescence decay rate is evidence for protection against
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Figure 10: Lipid peroxidation protection by negative control (PBS,
A), free quercetin 1 μM (B), free quercetin 3 μM (C), free quercetin
5 μM (D), encapsulated quercetin 1 μM (E), encapsulated quercetin
3 μM (F), and encapsulated quercetin 5 μM (G). Values represent
the means of three individual measurements.
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Figure 11: Lipid peroxidation protection by negative control (PBS,
A), free catechin 1 μM (B), free catechin 3 μM (C), free catechin
5 μM (D), encapsulated catechin 1 μM (E), encapsulated catechin
3 μM (F), and encapsulated catechin 5 μM (G). Values represent the
means of three individual measurements.
lipid oxidation. Free or encapsulated quercetin was added
to the solution containing phospholipid liposomes 2 hours
before starting the reduction reaction. A reducing agent
(AAPH) was then added to the system to promote lipid
peroxidation. Figures 10 and 11 show the fluorescence decay
rates of C11-BODIPY581/591 by ROO• radicals and the eﬀect
of free and encapsulated quercetin and catechin. As expected,
the evaluated systems inhibit the peroxidation reaction in a
concentration dependent manner. The lipid oxidation inhi-
bition was greater when quercetin or catechin were dispersed
within PLGA nanoparticles than when dispersed in water.
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Figure 12: Chelating activity of Fe2+ ions by free PLGA nanoparticles (aI, bI), free quercetin 20 μM (aII), free quercetin 100 μM
(aIII), encapsulated quercetin 20 μM (aIV), encapsulated quercetin 100 μM (aV), free catechin 20 μM (bII), free catechin 100 μM (bIII),
encapsulated catechin 20 μM (bIV), and encapsulated catechin 10 μM (bV). Diﬀerent letters represent significantly diﬀerence (P < 0.05)
between treatments at one specific time of experimentation (0.25, 4, 12, 24, and 32 h). Results are represented by the mean ± SE.
These results can be attributed to the protection of PLGA
nanoparticles during the incubation process to which they
were submitted during 2 h. Molecular oxygen formed by the
stirring process could degrade the unprotected flavonoids,
thus decreasing their antiradical properties. These results
showed that the antiradical capacity of both encapsulated
flavonoids remains after the encapsulation process. These
findings too suggest that these polymeric nanoparticles may
be useful for the incorporation of bioactive flavonoids with
the aim of inhibiting lipid oxidation reactions in either food
products or the human body.
3.5.3. Chelating Activity of Flavonoid-Loaded PLGA NPs.
Chelating activity directly influences the generation of
oxidant species thus constituting an important factor of
the antioxidant properties of a compound or system [24].
Thus, the ability to chelate iron ions (Fe2+) by free and
encapsulated flavonoids was evaluated (Figure 12). It can be
observed that the chelating activity of free quercetin and
free catechin (Figures 12(a) and 12(b), resp.) decreased over
time (0–32 hrs). This might be due to the degradation of
flavonoid molecules by molecular O2 formed during the
incubation and stirring processes. Encapsulated quercetin
and encapsulated catechin demonstrated an increase in
the chelating properties of Fe2+ ions. Protection of PLGA
nanoparticles allowed encapsulated quercetin or catechin to
remain stable during the time of experimentation, leading
to exerting their chelating capacity. In addition, it has
been suggested that the ultracentrifugation method might
aﬀect the release of encapsulated actives, forcing a faster
diﬀusion and spreading the molecules that are closer to
the nanoparticle surface and thus may produce a major
release of flavonoids from nanoparticles that reacted with
iron ions. Moreover, drug release from PLGA nanoparticles
could be increased by degradation of PLGA chains in the
presence of water by hydrolysis [30]. Although catechin has a
faster release from the polymeric nanoparticles compared to
quercetin, the chelating capacity of encapsulated quercetin
was higher, mainly due to its higher capacity to chelate
transition metal ions, as has been reported by other authors
[23, 56, 57].
4. Conclusions
Polymeric nanoparticles were prepared and used to encapsu-
late, protect, and release two bioactive flavonoid molecules,
quercetin and catechin.We showed that both flavonoids were
successfully encapsulated in a noncrystalline state within
the PLGA nanoparticles matrix, with an EE of ≈79%. Also
we showed that the release profile method used is suitable,
reproducible, and stable for these types of determinations.
The in vitro release profiles showed that quercetin and
catechin release rates are pH-dependent, liberating them in
a higher rate when the pH conditions of the environment
are more acidic. These results suggest that PLGA nanopar-
ticles could be suitable for the encapsulation of bioactive
compounds (such as flavonoids and vitamins) and to release
them in acidic environments, such as the stomach of some
food products. These findings could also be useful for the
design and fabrication of polymeric nanoparticles for the
targeted release of these compounds within stomach for the
treatment of local diseases or to release them in acidic food
products, producing novel functional foods. Also this study
showed that the use of PLGA nanoparticles increase the
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antiradical and chelating properties of these two flavonoids.
Therefore, these delivery systems may be suitable to increase
the shelf life of lipid food products or may be helpful
as novel therapeutic systems to delay the development of
diseases related to oxidative stress (e.g., diabetes mellitus
and cancer). Nevertheless, more studies are necessary to
demonstrate that PLGA nanoparticles can protect and release
these bioactive flavonoids within the gastrointestinal tract,
evaluating their bioaccessibility and bioavailability. Also
studies of the incorporation, release, and protection on a
model food product may be important to investigate. In
general, our results have important implications for the
design and fabrication of polymeric nanoparticle delivery
systems for bioactive compounds with beneficial properties
for human health and wellness.
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